Komori
Kitazato (368A) · RiskFirst stated

Risks of medical incidents, product recalls and shipment suspensions arising from product safety and quality issues

First written in FY2026. . Latest entry: FY2026.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Risk of product recalls and regulatory action due to serious quality issuesA theme 91 companies write about · 92 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2025: 13 of 35 companies on the "Worse" side.

5 other companies' latest entry also says "First stated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 91 companies compared. The sentences above are computed from all 91.
Full recordFilings, disclosures and news, newest first
  1. FY2026First statedAnnual report

    「If the safety or quality of the Company's products is compromised, medical incidents, litigation, product recalls, shipment suspensions and other consequences may occur.」

    The Company assesses the impact as high, the likelihood as high, and the timing of occurrence as anytime, with countermeasures including compliance with procedures, corrective action, education and training, and coordination between manufacturing and quality control.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Kitazato's next results are scheduled for 2026-10-28. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Risks of medical incidents, product recalls and shipment suspensions arising from product safety and quality issues | Kitazato Corporation (368A) | Komori